SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Pharmacyclics (PCYC)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
717 41 0 PCYC
Emcee:  Doug Meetmer Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
592Woodburn.... brings back old days and old lessons. Thanks, Stan. Good stuff scaram(o)uche-7/10/2000
591Couldn't link to the abstracts. 169.147.169.1 Photobiology in Cardiology Secsquetch-7/6/2000
590Thanks, Jason. No reason of course why this technique couldn't be combinedBiomaven-7/5/2000
589<i>New high-precision radiosurgery developed for brain tumors Jul 5, 2000 tnsaf-7/5/2000
588 Well that's a double in 12 trading days (for anyone who bought at the low tBiomaven-6/7/2000
587 Jason, No, I still hold PCYC, and in fact recently bought a little more. ItBiomaven-5/22/2000
586 Data from the lead-in patients of Xcytrin's P-III presented at ASCO, and sotnsaf-5/22/2000
585 squetch, Hope Pequot isn't in trouble as well - FWIW I saw a denial: MessBiomaven-4/28/2000
584 Peter, Pequot Capital Management was rumored to be in trouble and Yahoo! listedsquetch-4/28/2000
583 Jason, They have the usual provisions for an early look at the data by a DSMB.Biomaven-4/28/2000
582 Thanks, Peter. So 6 months to complete enrollment, 6 months for follow up, 3-6tnsaf-4/28/2000
581 <i>how far along the XCYTRIN trial is? </i> Well the non-random leBiomaven-4/24/2000
580 Does anyone have information on how far along the XCYTRIN trial is? It startedtnsaf-4/22/2000
579 PCYC is back at sale price again. This company is much more attractive to own Harold Engstrom-4/21/2000
578 Bought in to PCYC again today at 38. Never thought I'd see this price againRWReeves-4/14/2000
577 oooh! I got back in around $50, and $40, and now I'm looking at $32.... ialexis s-4/14/2000
576 Well I'm back in this week at around $50. Risk-reward looks good to me at tBiomaven-4/7/2000
575 A couple of patents from last week 6,022,959 Nucleic acids intersquetch-2/16/2000
574 I would love a chance to get back in here. I agree with your long term assessmeRWReeves-1/6/2000
573 I suspect we may see a short-attack on PCYC here (Sturza is short and I hazard Biomaven-1/6/2000
572 smh, PCYC now have a rebuttal on their web site (see below). This is consideraBiomaven-1/5/2000
571 Peter, The market certainly supports your thinking. However, I still find thismh-1/1/2000
570 One cautionary note, though - Brown does seem to be a respectable researcher inBiomaven-12/31/1999
569 smh, This explains the volatility in the stock. Personally, I added a little tBiomaven-12/31/1999
568 smh, Looks like Mr. Market feels it is BS, Best regards and Happy New Year. WTDEC-12/31/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News